NI
VRTX icon

Natural Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Natural Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
1,294
+29
+2% +$12.9K 0.14% 128
2026
Q1 		$565K Buy
1,265
+92
+8% +$42.9K 0.14% 143
2025
Q4 		$531K Buy
1,173
+225
+24% +$97K 0.13% 148
2025
Q3 		$371K Sell
948
-68
-7% -$28.4K 0.09% 169
2025
Q2 		$452K Buy
1,016
+199
+24% +$91.7K 0.12% 152
2025
Q1 		$396K Buy
817
+187
+30% +$87.1K 0.11% 162
2024
Q4 		$253K Buy
+630
New +$292K 0.07% 206

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Natural Investments's VRTX Position: Q2 2026 in Review

Natural Investments increased its Vertex Pharmaceuticals (VRTX) stake by 2.3% in Q2 2026, buying an estimated $12.9K and bringing the position to 1,294 shares worth $642K. The position accounts for 0.14% of the portfolio, ranked #128.

Natural Investments first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Natural Investments held 1,294 shares of Vertex Pharmaceuticals worth $642K as of Q2 2026.
  • Natural Investments bought 29 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Vertex Pharmaceuticals made up 0.14% of Natural Investments's portfolio in Q2 2026, its #128 holding.
  • Natural Investments first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.